These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28905781)

  • 1. Re: Effectiveness of Adjuvant Chemotherapy after Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma.
    Laguna MP
    J Urol; 2017 Oct; 198(4):739-740. PubMed ID: 28905781
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma.
    Xylinas E; Necchi A;
    Eur Urol; 2017 Sep; 72(3):473-474. PubMed ID: 28502719
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
    Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
    Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: Is There Sufficient Evidence?
    Biswas B; Ganguly S; Ghosh J; E P; Dabkara D
    J Clin Oncol; 2017 Jun; 35(18):2095-2096. PubMed ID: 28471709
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Association Between Lymph Node Yield and Survival Among Patients Undergoing Radical Nephroureterectomy for Urothelial Carcinoma of the Upper Tract.
    Petros FG; Matin SF
    Eur Urol; 2018 May; 73(5):811-812. PubMed ID: 29249290
    [No Abstract]   [Full Text] [Related]  

  • 6. Now Is the Time for Perioperative Chemotherapy in Upper Tract Urothelial Cancer.
    Siefker-Radtke AO; Campbell MT
    J Clin Oncol; 2017 Mar; 35(8):816-817. PubMed ID: 28165904
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
    Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.
    Winer AG; Vertosick EA; Ghanaat M; Corradi RB; Carlsson S; Sjoberg DD; Sankin AI; Sfakianos JP; Cha EK; Dalbagni G; Coleman JA
    Urol Oncol; 2017 Apr; 35(4):151.e9-151.e15. PubMed ID: 27932270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelial carcinoma: Adjuvant chemotherapy improves outcomes after RNU.
    Sidaway P
    Nat Rev Urol; 2017 Apr; 14(4):196-197. PubMed ID: 28117847
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration.
    Necchi A; Lo Vullo S; Mariani L; Moschini M; Hendricksen K; Rink M; Sosnowski R; Dobruch J; Raman JD; Wood CG; Margulis V; Roupret M; Briganti A; Montorsi F; Xylinas E; Shariat SF;
    BJU Int; 2018 Feb; 121(2):252-259. PubMed ID: 28940605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oncologic outcomes of high-risk upper tract urothelial carcinoma patients undergoing radical nephroureterectomy combined with adjuvant chemotherapy].
    Feng BF; Luo Y; Wei DC; Han YL; Li MC; Zhao JH; Lin YH; Hou Z; Jiang YG
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(2):115-119. PubMed ID: 30669749
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Lymphadenectomy During Radical Nephroureterectomy in Locally Advanced Upper Tract Urothelial Carcinoma.
    Ikeda M; Matsumoto K; Sakaguchi K; Ishii D; Tabata KI; Kurosawa K; Urakami S; Okaneya T; Iwamura M
    Clin Genitourin Cancer; 2017 Oct; 15(5):556-562. PubMed ID: 28501481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Efficacy of Systemic Chemotherapy plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma.
    Laguna MP
    J Urol; 2017 Dec; 198(6):1205-1206. PubMed ID: 29144939
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study.
    Lucca I; Kassouf W; Kapoor A; Fairey A; Rendon RA; Izawa JI; Black PC; Fajkovic H; Seitz C; Remzi M; Nyirády P; Rouprêt M; Margulis V; Lotan Y; de Martino M; Hofbauer SL; Karakiewicz PI; Briganti A; Novara G; Shariat SF; Klatte T
    BJU Int; 2015 Jul; 116(1):72-8. PubMed ID: 24825476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma.
    Huang YC; Chen MF; Shi CS; Shindel AW; Huang CE; Pang ST; Chuang CK; Chen CS; Chang YH; Lin WY; Ho DR; Chin CC; Kuo YH; Wu CF
    J Urol; 2015 Aug; 194(2):323-9. PubMed ID: 25796114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T
    Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
    Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
    World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience.
    Shirotake S; Kikuchi E; Tanaka N; Matsumoto K; Miyazaki Y; Kobayashi H; Ide H; Obata J; Hoshino K; Kaneko G; Hagiwara M; Kosaka T; Kanao K; Kodaira K; Hara S; Oyama M; Momma T; Miyajima A; Nakagawa K; Hasegawa S; Nakajima Y; Oya M
    J Urol; 2015 Apr; 193(4):1122-8. PubMed ID: 25444957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes.
    Kobayashi K; Saito T; Kitamura Y; Bilim V; Toba T; Kawasaki T; Hara N; Tanikawa T; Tomita Y
    Int J Urol; 2016 Feb; 23(2):153-8. PubMed ID: 26607995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis.
    Kim DK; Lee JY; Kim JW; Hah YS; Cho KS
    Crit Rev Oncol Hematol; 2019 Mar; 135():59-65. PubMed ID: 30819447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.